Strategic collaborations have long played an instrumental role in the development of complex inhalation products. When well executed, they can have exponential benefits on pharmaceutical companies, patients, and society. With this common purpose and vision DFE Pharma, Sterling S.P.A. and Harro Höfliger, have entered a unique cooperation in the respiratory medicine development field with more than 100 years of combined experience, supporting pharmaceutical companies and their respiratory product development. INTO is a combined service offering collective accountability increasing efficiency and effectiveness and making complex respiratory drug product development simple, fast, economic and easy to manage by offering a co-ordinated and aligned suite of services in one team, no gaps, everyone aligned and focused on meeting the clients’ targets, together. Enhanced Product development leveraging a unified set of skills and consolidated expertise.